Attached files
file | filename |
---|---|
8-K - FORM 8-K - METLIFE INC | y85858e8vk.htm |
EX-1.3 - EX-1.3 - METLIFE INC | y85858exv1w3.htm |
EX-1.6 - EX-1.6 - METLIFE INC | y85858exv1w6.htm |
EX-1.1 - EX-1.1 - METLIFE INC | y85858exv1w1.htm |
EX-1.5 - EX-1.5 - METLIFE INC | y85858exv1w5.htm |
EX-1.4 - EX-1.4 - METLIFE INC | y85858exv1w4.htm |
Exhibit 1.2
PRICING AGREEMENT
August 2, 2010
Merrill Lynch, Pierce, Fenner & Smith Incorporated
Credit Suisse Securities (USA) LLC
Deutsche Bank Securities Inc.
HSBC Securities (USA) Inc.
UBS Securities LLC
Wells Fargo Securities, LLC
As Representatives of the several Underwriters
named in Schedule I hereto
Credit Suisse Securities (USA) LLC
Deutsche Bank Securities Inc.
HSBC Securities (USA) Inc.
UBS Securities LLC
Wells Fargo Securities, LLC
As Representatives of the several Underwriters
named in Schedule I hereto
c/o Merrill Lynch, Pierce, Fenner & Smith Incorporated
One Bryant Park
New York, New York 10036
c/o Deutsche Bank Securities Inc.
60 Wall Street
New York, New York 10005
One Bryant Park
New York, New York 10036
c/o Deutsche Bank Securities Inc.
60 Wall Street
New York, New York 10005
Ladies and Gentlemen:
MetLife, Inc., a Delaware corporation (the Company), proposes, subject to the terms
and conditions stated herein (this Agreement) and in the Underwriting Agreement, dated
August 2, 2010 (the Underwriting Agreement), to issue and sell to the Underwriters
named in Schedule I hereto (the Underwriters) the total number of shares of the Companys
common stock, par value $0.01 per share specified in Schedule I hereto (the Firm
Securities) at the purchase price per share specified in Schedule II hereto. In addition, the
Company proposes, subject to the terms and conditions stated in this Agreement and the Underwriting
Agreement, to grant to the Underwriters the option, exerciseable solely for the purpose of covering
over-allotments made in connection with the sale of the Firm Securities at any time not more than
30 days subsequent to the date of the Final Prospectus, to purchase all or less than all of the
number of shares specified on Schedule II hereto as the Optional Securities at the
purchase price per share to be paid for the Firm Securities.
Each of the provisions of the Underwriting Agreement is incorporated herein by reference in
its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such
provisions had been set forth in full herein; and each of the representations and warranties set
forth therein shall be deemed to have been made at and as of the date of this Agreement, the
Applicable Time and the Closing Date. Each reference to the Representatives herein and in the
provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to
you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein
as therein defined. The Firm Securities and the Optional Securities shall be considered Securities
under the Underwriting Agreement. The Representatives designated to act on behalf of the
Representatives and on behalf of each of the Underwriters of the Securities
pursuant to the Underwriting Agreement and the address of the Representatives are set forth at
the end of Schedule II hereto.
Subject to the terms and conditions set forth herein and in the Underwriting Agreement
incorporated herein by reference, the Company agrees to issue, sell and deliver to each of the
Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the
Company, at the time and place and at the purchase price to the Underwriters set forth in Schedule
II hereto, the number of Firm Securities set forth opposite the name of such Underwriter in
Schedule I hereto. The date of the issuance, sale and delivery of the Firm Securities is the
First Closing Date set forth on Schedule II hereto and such date shall be considered a
Closing Date under the Underwriting Agreement.
If the Representatives give written notice to the Company at any time not more than 30 days
subsequent to the date of the Final Prospectus, then, subject to the terms and conditions set forth
herein and in the Underwriting Agreement incorporated herein by reference, the Company agrees to
issue and sell to each of the Underwriters, and each of the Underwriters agrees, severally and not
jointly, to purchase from the Company the percentage of the total number of Optional Securities
specified in such notice that equals the percentage set forth opposite such Underwriters name on
Schedule I hereto (subject to adjustment by the Representatives to eliminate fractions). Optional
Securities may be purchased by the Underwriters solely for the purpose of covering over-allotments
made in connection with the sale of the Firm Securities. No Optional Securities shall be sold or
delivered unless the Firm Securities previously have been, or simultaneously are, sold and
delivered. The right to purchase the Optional Securities or any portion thereof may be exercised
at any time and to the extent not previously exercised may be surrendered and terminated at any
time upon notice by the Representatives to the Company. Each time for the delivery of and payment
for the Optional Securities (each, an Optional Closing Date) may be the First Closing
Date and each Optional Closing Date, if any, shall be considered a Closing Date under the
Underwriting Agreement. Each Optional Closing Date shall be determined by the Representatives but
shall be not later than five full business days after written notice of election to purchase
Optional Securities is given.
If the foregoing is in accordance with your understanding, please sign and return to us
counterparts hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this
letter and such acceptance hereof, including the provisions of the Underwriting Agreement
incorporated herein by reference, shall constitute a binding agreement between each of the
Underwriters and the Company. It is understood that your acceptance of this letter on behalf of
each of the Underwriters is or will be pursuant to the authority set forth in a form of Agreement
among Underwriters, the form of which shall be submitted to the Company for examination upon
request, but without warranty on the part of the Representatives as to the authority of the signers
thereof.
[Signature pages follow]
2
Very truly yours, METLIFE, INC. |
||||
By: | /s/ Steven J. Goulart | |||
Name: | Steven J. Goulart | |||
Title: | Senior Vice President and Treasurer | |||
[Signature page to Common Stock Pricing Agreement]
Accepted as of the date hereof
on behalf of each of the Underwriters:
on behalf of each of the Underwriters:
MERRILL LYNCH, PIERCE, FENNER &
SMITH INCORPORATED
SMITH INCORPORATED
By: | /s/ Paul Brown | |||
Name: | Paul Brown | |||
Title: | Managing Director | |||
[Signature page to Common Stock Pricing Agreement]
CREDIT SUISSE SECURITIES (USA) LLC
By: | /s/ David M. Platter | |||
Name: | David M. Platter | |||
Title: | Managing Director | |||
[Signature page to Common Stock Pricing Agreement]
DEUTSCHE BANK SECURITIES INC.
By: | /s/ Jeffrey Mortara | |||
Name: | Jeffrey Mortara | |||
Title: | Managing Director | |||
By: | /s/ Brad Miller | |||
Name: | Brad Miller | |||
Title: | Managing Director | |||
[Signature page to Common Stock Pricing Agreement]
HSBC SECURITIES (USA) INC.
By: | /s/ David Noble | |||
Name: | David Noble | |||
Title: | Managing Director | |||
[Signature
page to Common Stock Pricing Agreement]
UBS SECURITIES LLC
By: | /s/ Michael B. Ostow | |||
Name: | Michael B. Ostow | |||
Title: | Managing Director | |||
By: | /s/ Tushar Virmani | |||
Name: | Tushar Virmani | |||
Title: | Associate Director | |||
[Signature page to Common Stock Pricing Agreement]
WELLS FARGO SECURITIES, LLC
By: | /s/ David Herman | |||
Name: | David Herman | |||
Title: | Director | |||
[Signature page to Common Stock Pricing Agreement]
SCHEDULE I
TO PRICING AGREEMENT
TO PRICING AGREEMENT
Number of Firm | ||||||||
Securities to be | Percentage of | |||||||
Underwriters | Purchased | Optional Securities | ||||||
Merrill Lynch, Pierce, Fenner & Smith Incorporated |
12,024,825 | 16.03 | % | |||||
Credit Suisse Securities (USA) LLC |
12,024,825 | 16.03 | % | |||||
Deutsche Bank Securities Inc. |
12,024,825 | 16.03 | % | |||||
HSBC Securities (USA) Inc. |
5,789,700 | 7.72 | % | |||||
UBS Securities LLC |
5,789,700 | 7.72 | % | |||||
Wells Fargo Securities, LLC |
5,789,700 | 7.72 | % | |||||
Sanford C. Bernstein & Co, LLC |
777,475 | 1.04 | % | |||||
Macquarie Capital (USA) Inc. |
777,475 | 1.04 | % | |||||
Sterne, Agee & Leach, Inc. |
777,475 | 1.04 | % | |||||
BNP Paribas Securities Corp. |
1,425,000 | 1.90 | % | |||||
RBS Securities Inc. |
1,425,000 | 1.90 | % | |||||
SG Americas Securities, LLC |
1,425,000 | 1.90 | % | |||||
Cowen and Company, LLC |
1,087,500 | 1.45 | % | |||||
Daiwa Capital Markets America Inc. |
1,087,500 | 1.45 | % | |||||
Dowling & Partners Securities, LLC |
1,087,500 | 1.45 | % | |||||
PNC Capital Markets LLC |
1,087,500 | 1.45 | % | |||||
Scotia Capital (USA) Inc. |
1,087,500 | 1.45 | % | |||||
UniCredit Capital Markets, Inc. |
1,087,500 | 1.45 | % | |||||
The Williams Capital Group, L.P. |
990,750 | 1.32 | % | |||||
BNY Mellon Capital Markets, LLC |
750,000 | 1.00 | % | |||||
Commerz Markets LLC |
750,000 | 1.00 | % | |||||
Mitsubishi UFJ Securities (USA), Inc. |
750,000 | 1.00 | % | |||||
Raymond James & Associates, Inc. |
750,000 | 1.00 | % | |||||
Santander Investment Securities Inc. |
750,000 | 1.00 | % | |||||
Loop Capital Markets LLC |
495,000 | 0.65 | % | |||||
Blaylock Robert Van LLC |
490,500 | 0.65 | % | |||||
Cabrera Capital Markets, LLC |
490,500 | 0.65 | % | |||||
Guzman & Company |
490,500 | 0.65 | % | |||||
Muriel Siebert & Co., Inc. |
490,500 | 0.65 | % | |||||
Samuel A. Ramirez & Co., Inc. |
490,500 | 0.65 | % | |||||
CastleOak Securities, L.P. |
245,250 | 0.33 | % | |||||
MFR Securities, Inc. |
245,250 | 0.33 | % | |||||
Toussaint Capital Partners, LLC |
245,250 | 0.33 | % | |||||
Total |
75,000,000 | 100.00 | % |
SI-1
SCHEDULE II
TO PRICING AGREEMENT
TO PRICING AGREEMENT
Underwriting Agreement, dated August 2, 2010
Registration Statement No. 333-147180
INITIAL
PRICE TO THE PUBLIC: $42.00
PURCHASE
PRICE BY UNDERWRITERS: $40.92
NUMBER OF FIRM SECURITIES: 75,000,000
NUMBER OF OPTIONAL SECURITIES: 11,250,000
PARTIES TO LOCK-UP AGREEMENTS:
C. Robert Henrikson
Gwenn L. Carr
Kathleen Henkel
Steven A. Kandarian
Nicholas D. Latrenta
Maria R. Morris
William J. Mullaney
William J. Toppeta
William J. Wheeler
Sylvia Mathews Burwell
Eduardo Castro-Wright
Cheryl W. Grisé
R. Glenn Hubbard
John M. Keane
Alfred F. Kelly, Jr.
James M. Kilts
Catherine R. Kinney
Hugh B. Price
David Satcher, M.D.
Kenton J. Sicchitano
Lulu C. Wang
Gwenn L. Carr
Kathleen Henkel
Steven A. Kandarian
Nicholas D. Latrenta
Maria R. Morris
William J. Mullaney
William J. Toppeta
William J. Wheeler
Sylvia Mathews Burwell
Eduardo Castro-Wright
Cheryl W. Grisé
R. Glenn Hubbard
John M. Keane
Alfred F. Kelly, Jr.
James M. Kilts
Catherine R. Kinney
Hugh B. Price
David Satcher, M.D.
Kenton J. Sicchitano
Lulu C. Wang
FIRST CLOSING DATE: August 6, 2010
TIME OF FIRST CLOSING: 10 A.M.
LOCATION OF FIRST CLOSING: the offices of Debevoise & Plimpton LLP, 919 Third Avenue, New York, New
York 10022
REPRESENTATIVES: Merrill Lynch, Pierce, Fenner & Smith Incorporated,
Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc.,
HSBC Securities (USA) Inc., UBS Securities LLC and Wells Fargo Securities, LLC
SII-1
ADDRESSES FOR NOTICES, ETC.:
IF TO THE REPRESENTATIVES:
Merrill Lynch, Pierce, Fenner & Smith Incorporated
One Bryant Park
New York, New York 10036
Attention: Syndicate Department (Facsimile: 646-855-3073), with a copy to:
ECM Legal (Facsimile: 212-230-8730)
One Bryant Park
New York, New York 10036
Attention: Syndicate Department (Facsimile: 646-855-3073), with a copy to:
ECM Legal (Facsimile: 212-230-8730)
Deutsche Bank Securities Inc.
60 Wall Street
New York, New York 10005
Attention: ECM Syndicate Desk (Facsimile: 212-797-9344), with a copy to:
General Counsel (Facsimile: 212-797-4564)
60 Wall Street
New York, New York 10005
Attention: ECM Syndicate Desk (Facsimile: 212-797-9344), with a copy to:
General Counsel (Facsimile: 212-797-4564)
IF TO THE COMPANY:
MetLife, Inc.
1095 Avenue of the Americas
New York, New York 10036
Attention: General Counsel
1095 Avenue of the Americas
New York, New York 10036
Attention: General Counsel
SII-2